U.S. company trials coronavirus vaccine in Australia
5/27/20
from The Philadelphia Inquirer,
5/25/20:
A U.S. biotechnology company announced on Tuesday the start of human trials in Australia of a vaccine for the coronarvirus with hopes of releasing a proven vaccine this year.
Novavax has begun the first phase of the trial in which 131 volunteers in the cities of Melbourne and Brisbane will test the safety of the vaccine and look for early signs of the vaccine’s effectiveness, the company’s research chief Dr. Gregory Glenn said.
More From The Philadelphia Inquirer:
